3-Dimensional micropillar drug screening identifies FGFR2-IIIC overexpression as a potential target in metastatic giant cell tumor

por Kim, Seung Tae, Kim, Jusun, Shin, Sumin, Kim, Sun Young, Lee, Dongwoo, Ku, Bosung, Shin, Yong Sung, Kim, Jhingook, Lee, Jeeyun
Publicado 2017

Loss of Tuberous Sclerosis Complex 2 (TSC2) as a Predictive Biomarker of Response to mTOR Inhibitor Treatment in Patients with Hepatocellular Carcinoma()

por Cho, Jinhyun, Lee, Jeeyun, Kim, Jusun, Kim, Seung Tae, Lee, Sujin, Kim, Sun Young, Ha, Sang Yun, Park, Cheol-Keun, Lim, Ho Yeong
Publicado 2016

Systematic Evaluation of Gastric Tumor Cell Index and Two-Drug Combination Therapy via 3-Dimensional High-Throughput Drug Screening

por Lim, Sung Hee, Sa, Jason K., Lee, Dong Woo, Kim, Jusun, Kim, Seung Tae, Park, Se Hoon, Ku, Bosung, Park, Joon Oh, Park, Young Suk, Lim, Hoyeong, Kang, Won Ki, Nam, Do-Hyun, Lee, Jeeyun
Publicado 2019

Acquired resistance to LY2874455 in FGFR2-amplified gastric cancer through an emergence of novel FGFR2-ACSL5 fusion

por Kim, Sun Young, Ahn, Taejin, Bang, Heejin, Ham, Jun Soo, Kim, Jusun, Kim, Seung Tae, Jang, Jiryeon, Shim, Moonhee, Kang, So Young, Park, Se Hoon, Min, Byung Hoon, Lee, Hyuk, Kang, Won Ki, Kim, Kyoung-Mee, Park, Woongyang, Lee, Jeeyun
Publicado 2017